(Q43251078)

English

An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure

scientific article published on 30 October 2009

Statements

An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure (English)
Michael R Bristow
Guinevere A Murphy
Heidi Krause-Steinrauf
Jeffrey L Anderson
John F Carlquist
Surai Thaneemit-Chen
Vaishali Krishnan
J David Port
Gordon W Davis
Alastair D Robertson
Phillip W Lavori
Stephen B Liggett
30 October 2009
21-28

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit